Company page

Protagonist Therapeutics, Inc.

Protagonist Therapeutics, Inc. (PTGX) is a publicly traded company based in the United States, with a market capitalization of approximately $7.26 billion. The company focuses on developing innovative therapies for various medical conditions. Its commitment to advancing healthcare solutions positions it as a notable player in the biotechnology sector.

profilePTGX:NASDAQAI content: aiUpdated June 24, 2026/company/protagonist-therapeutics-inc/c-xq15ieoj
Protagonist Therapeutics, Inc. logo
Ticker
PTGX:NASDAQ
Asset type
Stock
Market cap
$7.26B
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD